TORONTO, ON / ACCESSWIRE / December 3, 2020 / Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) (“Kontrol” or “Company“) is pleased to announce that the Company is in receipt of advisory services and up to $500,000 in research and development funding from National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to complete final commercialization and mass production requirements for its Covid-19 technology, the Kontrol BioCloudTM analyzer (“BioCloud analyzer” or “BioCloud“).
“This is another important accomplishment and milestone for Kontrol and represents the continuing advancement of the BioCloud technology,” says Paul Ghezzi, CEO Kontrol. “The focus of our BioCloud technology is to help create safe spaces for all as we collectively continue to face the challenge of the COVID-19 pandemic. We are thankful for this support from NRC IRAP.”
The Company has commenced initial production of BioCloud units for